“The apprehension with using non IID mentioned ingredients is justified as it is extremely hard to evaluate if FDA would find the ‘novel excipient’ Risk-free to be used inside of a drug product or service as there is no defined method for analysis and acceptance of excipients. The FDA https://walesc613fzw3.wikiconverse.com/user